Elevance Health, Inc. 8-K Filing Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated October 31, 2024, reports on a debt offering event that occurred on October 22, 2024. Elevance Health, Inc. (NYSE: ELV) closed a multi-series senior notes offering to raise capital for general corporate purposes.
Key Financial Metrics and Capital Structure
The Company issued a total of $5.2 billion in aggregate principal amount of senior notes across six maturities. The net proceeds received were approximately $5,138.3 million after deducting underwriting discounts and offering expenses.
| Note Series | Principal Amount | Coupon Rate | Maturity Date |
|---|---|---|---|
| 2026 Notes | $350 million | 4.500% | October 30, 2026 |
| 2030 Notes | $750 million | 4.750% | February 15, 2030 |
| 2031 Notes | $750 million | 4.950% | November 1, 2031 |
| 2035 Notes | $1,200 million | 5.200% | February 15, 2035 |
| 2055 Notes | $1,350 million | 5.700% | February 15, 2055 |
| 2064 Notes | $800 million | 5.850% | November 1, 2064 |
Interest payments are semi-annual, with the first payments commencing between February and May 2025 depending on the series.
Material Changes and Use of Proceeds
This filing represents a significant increase in the Company's long-term debt obligations. The net proceeds of approximately $5.14 billion are designated for:
- Working capital and general corporate purposes.
- Funding of acquisitions.
- Repayment of short-term and long-term debt.
- Repurchase of common stock under the Company's share repurchase program.
The filing does not provide specific revenue, profit, or cash flow metrics for the reporting period, as this is a transactional filing rather than a periodic financial report.
Outlook, Risks, and Covenants
The Indenture governing the Notes does not prohibit or limit the incurrence of additional indebtedness. Key terms include:
- Redemption: The Company may redeem notes prior to specific "Par Call Dates" at a price equal to the greater of 100% of principal or the present value of remaining payments plus a make-whole premium. After the Par Call Date, notes may be redeemed at 100% of principal.
- Change of Control: If a change of control occurs and the notes are downgraded below investment grade by Moody's, S&P, and Fitch, the Company must offer to repurchase the notes at 101% of principal plus accrued interest.
- Events of Default: Include failure to pay principal or interest, breach of indenture terms, and bankruptcy proceedings.
Investor Verification Checklist
- Verify the exact allocation of the $5.138 billion net proceeds between debt repayment, acquisitions, and share buybacks in subsequent quarterly reports.
- Monitor the Company's credit ratings from Moody's, S&P, and Fitch to assess the risk of triggering the change-of-control repurchase provision.
- Review the impact of the new interest expense on future earnings per share (EPS) and free cash flow.
- Confirm the specific underwriting discounts paid, as the gross proceeds were $5.2 billion while net proceeds were $5.1383 billion.